UK Catapult: QbD and process automation key for making commercial cell therapies – BioPharma-Reporter.com
BioPharma-Reporter.com |
UK Catapult: QbD and process automation key for making commercial cell therapies
BioPharma-Reporter.com For the increasing number of stem cell therapies and regenerative products in development, there are a range of tools and equipment available for production at laboratory-scale, but industry lacks standard controlled, robust, reproducible and cost … |
